Citation Impact
Citing Papers
Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing
2006
Platelet gene expression and function in patients with COVID-19
2020 Standout
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Cutaneous leishmaniasis: current and future management
2003
Chagas disease
2010 Standout
Platelet function in HIV plus dengue coinfection associates with reduced inflammation and milder dengue illness
2019
Polymerase chain reaction (PCR) is highly sensitive for diagnosis of mucosal leishmaniasis
2005
No health without mental health
2007 Standout
Leishmaniasis
2018 Standout
Quinolines and structurally related heterocycles as antimalarials
2010 Standout
Neglected tropical diseases
2009 Standout
Antihelminthic Therapy and Antimony in Cutaneous Leishmaniasis: A Randomized, Double-Blind, Placebo-Controlled Trial in Patients Co-Infected with Helminths and Leishmania braziliensis
2011
Disseminated Leishmaniasis: A New and Emerging Form of Leishmaniasis Observed in Northeastern Brazil
2002
Species-Directed Therapy for Leishmaniasis in Returning Travellers: A Comprehensive Guide
2014
Mechanisms underlying immunosuppression induced by Trypanosoma cruzi
1990
Stroke Correlates in Chagasic and Non-Chagasic Cardiomyopathies
2012
Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations
2009
The Neglected Tropical Diseases of Latin America and the Caribbean: A Review of Disease Burden and Distribution and a Roadmap for Control and Elimination
2008 Standout
Cutaneous leishmaniasis
2007 Standout
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Taenia solium cysticercosis
2003 Standout
The gut microbiota of insects – diversity in structure and function
2013 Standout
Induction of cardiac autoimmunity in Chagas heart disease: A case for molecular mimicry
2006
Detection of pathogenic Leptospira spp. through TaqMan polymerase chain reaction targeting the LipL32 gene
2009 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Malaria
2013 Standout
Can primaquine therapy for vivax malaria be improved?
2003
Cloning and analysis of a cecropin gene from the malaria vector mosquito, Anopheles gambiae
2000 StandoutNobel
Identification of glycoproteins targeted by Trypanosoma cruzi trans-sialidase, a virulence factor that disturbs lymphocyte glycosylation
2010 StandoutNobel
Insecticide-treated materials for malaria control in Latin America: to use or not to use?
1999
Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost?
2013 Standout
Update on Myocarditis
2012 Standout
Myocarditis
2000 Standout
Artemisinin combination therapy for vivax malaria
2010
Clinical Utility of Polymerase Chain Reaction--Based Detection of Leishmania in the Diagnosis of American Cutaneous Leishmaniasis
2003
Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil
2004
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Severe falciparum malaria
2004 Standout
Evaluation and Treatment of Chagas Disease in the United States
2007
Platelets in Immune Response to Virus and Immunopathology of Viral Infections
2018
Is Paromomycin an Effective and Safe Treatment against Cutaneous Leishmaniasis? A Meta-Analysis of 14 Randomized Controlled Trials
2009
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
A Critical Review on Chagas Disease Chemotherapy
2002 Standout
Alpha beta T cell response to Toxoplasma gondii in previously unexposed individuals.
1998
Interventions for American cutaneous and mucocutaneous leishmaniasis
2009
Prevention of insect-borne disease: An approach using transgenic symbiotic bacteria
1997 Nobel
The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden
2001 Standout
Implications of genetic variability of Trypanosoma cruzi for the pathogenesis of Chagas disease
2007
Estudo comparativo da eficácia de isotionato de pentamidina administrada em três doses durante uma semana e de N-metil-glucamina 20mgSbV/kg/dia durante 20 dias para o tratamento da forma cutânea da leishmaniose tegumentar americana
2003
Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy.
1989
Sustainable vector control and management of Chagas disease in the Gran Chaco, Argentina
2007
Advances in leishmaniasis
2005 Standout
Mucosal leishmaniasis ("espundia") responsive to low dose of N-methyl glucamine (Glucantime ®) in Rio de Janeiro, Brazil
2000
Regulation of Trypanosoma cruzi-Induced Myocarditis by Programmed Death Cell Receptor 1
2011 StandoutNobel
From Proof of Concept to Scalable Policies: Challenges and Solutions, with an Application
2017 StandoutNobel
Thrombocytopenia and Platelet Dysfunction in Acute Tropical Infectious Diseases
2018
Innate and Acquired Immunity in the Pathogenesis of Chagas Disease
2004
Insecticide-treated bed nets and curtains for preventing malaria
2004 Standout
Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.
1989 Standout
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Chagas disease
2006
Cardiac Involvement with Parasitic Infections
2010
Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)
2016
Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies?
2009
Etiology of epilepsy a prospective study of 210 cases
1991
Drug Resistance in Leishmaniasis
2006 Standout
Mucosal leishmaniasis (“spundia” Escomel, 1911)
1986
From Proof of Concept to Scalable Policies: Challenges and Solutions, with an Application
2016 StandoutNobel
Tissue factor induction in human monocytes. Two distinct mechanisms displayed by different alloantigen-responsive T cell clones.
1985
Mechanisms of pathogenesis in Chagas disease
2006
Phytochemical Screening and Antioxidant Activities of Some Selected Medicinal Plants Used for Malaria Therapy in Southwestern Nigeria
2008 Standout
Platelet proteome reveals novel pathways of platelet activation and platelet-mediated immunoregulation in dengue
2017
Platelet Activation and Apoptosis Modulate Monocyte Inflammatory Responses in Dengue
2014
Works of Vanize Macêdo being referenced
Estudo comparativo entre antlmoniato de meglumina, isotianato de pentamidina e sulfato de aminosidine, no tratamento de lesões cutâneas primárias causadas por Leishmania (viannia) braziliensis
1996
Estudo radiológico longitudinal do esôfago, em área endêmica de doença de Chagas, em um período de seis anos
1992
Clinical observations of unresponsive mucosal leishmaniasis.
1998
The rarity of infection withLeishmania (Viannia) braziliensisamong patients from the Manaus region of Amazonas state, Brazil, who have cutaneous leishmaniasis
2002
Estudo radiológico longitudinal do esôfago, em área endêmica de doença de Chagas, em um período de 13 anos
1994
Sensitivity of the polymerase chain reaction for the diagnosis of cutaneous leishmaniasis due to Leishmania (Viannia) guyanensis
2001
Estudo terapêutico aberto com sulfato de aminosidine na leishmaniose mucosa causada for Leishmania (viannia) braziliensis
1996
Thrombocytopenia in patients with dengue virus infection in the Brazilian Amazon
2007
Diagnostic electrocardiography in epidemiological studies of Chagas' disease: multicenter evaluation of a standardized method
1998
Morbidity of Chagas' heart disease
1984
Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon region
1999
Ação de mosquiteiros impregnados com deltametrina sobre a morbidade da malária em uma área da Amazônia Brasileira
1998
Tratamento da Doença de Chagas pelo Nifurtimox (Bayer 2502)
1975
Características clínicas da leishmaniose tegumentar em crianças de 0 a 5 anos em uma área endêmica de Leishmania (Viannia) braziliensis
2006
Tratamento da leishmaniose mucosa com sulfato de aminosidine: resultados de dois anos de acompanhamento
1998
Trypanosoma Cruzi-Sensitized T-Lymphocyte Mediated 51Cr Release from Human Heart Cells in Chagas' Disease
1978
Avaliação do impacto das ações de controle vetorial da doença de Chagas através do inquérito sorológico em Mambaí/Buritinópolis, Goiás
2002
Acquired Cell-Mediated Immunodepression in Acute Chagas' Disease
1978
Influência da parasitemia na evolução da doença de Chagas crônica
2005
Estudo soroepidemiológico da cisticercose humana em Brasília, Distrito Federal
1986
Estudo clínico da malária falciparum em crianças em Manaus, AM, Brasil
2000
Parasite persistence in treated chagasic patients revealed by xenodiagnosis and polymerase chain reaction
2001
Indeterminate form of Chagas disease
1999
Polymerase chain reaction (PCR) as a laboratory tool for the evaluation of the parasitological cure in Chagas disease after specific treatment.
1999